| Id |
Subject |
Object |
Predicate |
Lexical cue |
db_id |
| 2567 |
5-16 |
ChemicalEntity |
denotes |
domperidone |
MESH:D004294 |
| 2568 |
28-39 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2569 |
51-73 |
DiseaseOrPhenotypicFeature |
denotes |
restless legs syndrome |
MESH:D012148 |
| 2570 |
154-176 |
DiseaseOrPhenotypicFeature |
denotes |
restless legs syndrome |
MESH:D012148 |
| 2571 |
178-181 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2572 |
213-216 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2573 |
249-257 |
ChemicalEntity |
denotes |
levodopa |
MESH:D007980 |
| 2574 |
262-270 |
ChemicalEntity |
denotes |
dopamine |
MESH:D004298 |
| 2575 |
297-329 |
ChemicalEntity |
denotes |
dopamine D2 receptor antagonists |
MESH:D065127 |
| 2576 |
354-357 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2577 |
432-443 |
ChemicalEntity |
denotes |
domperidone |
MESH:D004294 |
| 2578 |
458-478 |
GeneOrGeneProduct |
denotes |
dopamine D2 receptor |
NCBIGene:1813 |
| 2579 |
532-535 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2580 |
537-548 |
ChemicalEntity |
denotes |
Mirtazapine |
MESH:D000078785 |
| 2581 |
560-614 |
ChemicalEntity |
denotes |
noradrenergic and specific serotonergic antidepressant |
MESH:D000928 |
| 2582 |
616-621 |
ChemicalEntity |
denotes |
NaSSA |
MESH:D000928 |
| 2583 |
649-652 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2584 |
711-720 |
DiseaseOrPhenotypicFeature |
denotes |
depressed |
MESH:D003866 |
| 2585 |
721-728 |
OrganismTaxon |
denotes |
patient |
NCBITaxon:9606 |
| 2586 |
743-765 |
DiseaseOrPhenotypicFeature |
denotes |
postprandial dyspepsia |
MESH:D004415 |
| 2587 |
780-783 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2588 |
790-801 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2589 |
824-835 |
ChemicalEntity |
denotes |
domperidone |
MESH:D004294 |
| 2590 |
849-856 |
OrganismTaxon |
denotes |
patient |
NCBITaxon:9606 |
| 2591 |
885-888 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2592 |
925-936 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2593 |
946-949 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2594 |
1007-1018 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2595 |
1068-1079 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2596 |
1100-1103 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2597 |
1111-1118 |
OrganismTaxon |
denotes |
patient |
NCBITaxon:9606 |
| 2598 |
1160-1170 |
ChemicalEntity |
denotes |
domperione |
MESH:D004294 |
| 2599 |
1174-1185 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2600 |
1197-1200 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2601 |
1262-1273 |
ChemicalEntity |
denotes |
mirtazapine |
MESH:D000078785 |
| 2602 |
1297-1300 |
DiseaseOrPhenotypicFeature |
denotes |
RLS |
MESH:D012148 |
| 2603 |
1361-1393 |
ChemicalEntity |
denotes |
dopamine D2 receptor antagonists |
MESH:D065127 |
